Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion
15.5 هزار بار بازدید -
10 سال پیش
-
Visit
Visit http://www.ecancer.org for more.
Prof Giagounidis (St. John’s Hospital, Duisburg, Germany) chairs a discussion with Dr Zaja (University of Udine, Udine, Italy), Dr Liebman (University of Southern California, Los Angeles, USA), and Dr Bussel (Cornell University, Ithaca, USA) for ecancertv at EHA 2014 about the latest in ITP treatment options.
In particular, they discuss the latest clinical evidence and best treatment practice in chronic adult ITP, present the latest long-term data for TPO-R agonists with a focus on eltrombopag, and give expert insight into the management of challenging cases of chronic adult ITP.
Read the prescribing information here: http://share.ecancer.org/GSKEHAPrescr...
Content taken from a GlaxoSmithKline sponsored satellite symposium at EHA 2014 as part of the official programme.
Date of preparation: July 2014, OF/ELT/0079/14a
Prof Giagounidis (St. John’s Hospital, Duisburg, Germany) chairs a discussion with Dr Zaja (University of Udine, Udine, Italy), Dr Liebman (University of Southern California, Los Angeles, USA), and Dr Bussel (Cornell University, Ithaca, USA) for ecancertv at EHA 2014 about the latest in ITP treatment options.
In particular, they discuss the latest clinical evidence and best treatment practice in chronic adult ITP, present the latest long-term data for TPO-R agonists with a focus on eltrombopag, and give expert insight into the management of challenging cases of chronic adult ITP.
Read the prescribing information here: http://share.ecancer.org/GSKEHAPrescr...
Content taken from a GlaxoSmithKline sponsored satellite symposium at EHA 2014 as part of the official programme.
Date of preparation: July 2014, OF/ELT/0079/14a
10 سال پیش
در تاریخ 1393/05/22 منتشر شده
است.
15,591
بـار بازدید شده